Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q8N465: Variant p.Asn439Asp

D-2-hydroxyglutarate dehydrogenase, mitochondrial
Gene: D2HGDH
Feedback?
Variant information Variant position: help 439 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Asparagine (N) to Aspartate (D) at position 439 (N439D, p.Asn439Asp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (N) to medium size and acidic (D) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In D2HGA1; uncertain significance; mild phenotype; moderate reduction in catalytic activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 439 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 521 The length of the canonical sequence.
Location on the sequence: help RARLGPHAKHVVGYGHLGDG N LHLNVTAEAFSPSLLAALEP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         RARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEP

Mouse                         RTRLGPRAKHVVGYGHLGDGNLHLNVTAEAFSRELLGALEP

Rat                           RTRLGPRAKHVVGYGHLGDGNLHLNVTAEAFSQELLGALEP

Bovine                        RARLGPSAKHVVGYGHLGDGNLHLNVTSEAFSTSLLGALEP

Zebrafish                     RRHLGGMAKNVVGYGHVGDGNLHLNITSPSKDFDLLAAIEP

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 14 – 521 D-2-hydroxyglutarate dehydrogenase, mitochondrial
Binding site 434 – 434
Binding site 441 – 441
Binding site 443 – 443
Alternative sequence 314 – 521 Missing. In isoform 2.
Alternative sequence 320 – 521 Missing. In isoform 3.
Mutagenesis 434 – 434 H -> A. Loss of catalytic activity.
Mutagenesis 441 – 441 H -> A. Loss of catalytic activity.
Mutagenesis 443 – 443 N -> A. Significantly reduced catalytic activity.
Beta strand 439 – 448



Literature citations
Mutations in phenotypically mild D-2-hydroxyglutaric aciduria.
Struys E.A.; Korman S.H.; Salomons G.S.; Darmin P.S.; Achouri Y.; van Schaftingen E.; Verhoeven N.M.; Jakobs C.;
Ann. Neurol. 58:626-630(2005)
Cited for: VARIANT D2HGA1 ASP-439; CHARACTERIZATION OF VARIANT D2HGA1 ASP-439; FUNCTION; CATALYTIC ACTIVITY; Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria.
Kranendijk M.; Struys E.A.; Gibson K.M.; Wickenhagen W.V.; Abdenur J.E.; Buechner J.; Christensen E.; de Kremer R.D.; Errami A.; Gissen P.; Gradowska W.; Hobson E.; Islam L.; Korman S.H.; Kurczynski T.; Maranda B.; Meli C.; Rizzo C.; Sansaricq C.; Trefz F.K.; Webster R.; Jakobs C.; Salomons G.S.;
Hum. Mutat. 31:279-283(2010)
Cited for: VARIANTS D2HGA1 TRP-109; LYS-127; VAL-131; SER-147; THR-153; VAL-153; 169-GLN--ALA-521 DEL; TYR-172; LEU-189; VAL-205; VAL-231; SER-233; TYR-375; MET-399; 400-TYR--ALA-521 DEL; HIS-419; THR-426; ASP-439; ALA-444; VAL-446 AND ARG-477; CHARACTERIZATION OF VARIANTS D2HGA1 TRP-109; VAL-153; TYR-172; 400-TYR--ALA-521 DEL; HIS-419 AND THR-426; FUNCTION; CATALYTIC ACTIVITY; Structure, substrate specificity, and catalytic mechanism of human D-2-HGDH and insights into pathogenicity of disease-associated mutations.
Yang J.; Zhu H.; Zhang T.; Ding J.;
Cell Discov. 7:3-3(2021)
Cited for: X-RAY CRYSTALLOGRAPHY (2.21 ANGSTROMS) OF 51-521 IN COMPLEX WITH D-2-HYDROXYGLUTARATE; D-MALATE; D-LACTATE; L-2-HYDROXYGLUTARATE AND 2-OXOGLUTARATE; FUNCTION; CATALYTIC ACTIVITY; ZINC-BINDING SITES; BIOPHYSICOCHEMICAL PROPERTIES; MUTAGENESIS OF ARG-386; THR-390; LYS-401; HIS-434; HIS-441; ASN-443; GLU-475 AND HIS-476; CHARACTERIZATION OF VARIANTS D2HGA1 TRP-109; LYS-127; VAL-131; SER-147; THR-153; VAL-153; TYR-172; LEU-189; VAL-205; VAL-231; SER-233; TYR-375; MET-399; HIS-419; THR-426; ASP-439; ALA-444; VAL-446 AND ARG-477; CHARACTERIZATION OF VARIANT VAL-436;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.